Discussion
Diagnosis With Brief Discussion
- Diagnosis
- Radiation-induced sarcoma
- Radiologic Findings
- Figure 1. An axial enhanced CT image shows a heterogeneously enhancing mass with direct invasion of the adjacent chest wall and ribs at the periphery of the right upper lobe.
Figure 2. An axial enhanced CT image for lung cancer restaging shows a heterogeneously enhancing nodular lesion in the right pectoralis minor muscle, seven years after lung cancer treatment.
Figure 3. High FDG uptake is notable within the nodular lesion on the 18F-FDG PET/CT.
Figure 4. A percutaneous ultrasound-guided core needle biopsy was performed for the hypoechoic mass within the right pectoralis minor muscle. The pathological diagnosis was sarcoma.
Figure 5. This lesion is located within the field where radiotherapy was previously administered.
- Brief Review
- Radiation therapy (RT) is a primary treatment strategy for over half of cancer patients, significantly enhancing survival rates and long-term outcomes across various cancer types. Consequently, the utilization of RT continues to grow. For instance, a Korean study documented a 65% rise in cancer patients receiving RT between 2006 and 2013. However, despite its clear benefits, RT has been linked to the development of a rare iatrogenic malignancy known as "radiation-induced sarcoma" (RIS), accounting for approximately 3% of all soft tissue sarcomas. This condition is associated with poor prognosis, with 5-year overall survival rates ranging from 10% to 36%, depending on the disease stage at diagnosis. As such, RIS poses a significant challenge for physicians and is becoming an increasingly prevalent clinical issue, likely driven by the growing number of long-term cancer survivors achieved through advancements in cancer screening and management strategies.
A comprehensive analysis of the Surveillance, Epidemiology, and End Results (SEER) registries revealed a 257% higher risk of secondary bone sarcoma in patients who underwent RT compared to the general population. More recently, Snow et al. reviewed these findings and reported that breast cancer carries the second-highest risk of RIS after cervical cancer, with rates of 78.3% and 88.2%, respectively. RIS following RT for breast cancer encompasses a diverse range of histopathologic subtypes, with malignant fibrous histiocytoma being the most prevalent. Other, less common types include leiomyosarcoma, liposarcoma, fibrosarcoma, angiosarcoma, and, rarely, chondrosarcoma and osteosarcoma. These secondary RIS are typically high-grade tumors of varying sizes, characterized histologically by spindle-shaped tumor cells, hemorrhagic nodules, abundant mitotic activity, and areas of necrosis.
- References
- 1. Laurino S, Omer LC, Albano F, Marino G, Bianculli A, Solazzo AP, Sgambato A, Falco G, Russi S, Bochicchio AM. Radiation-induced sarcomas: A single referral cancer center experience and literature review. Front Oncol. 2022 Sep 30;12:986123.
2. Joo MW, Kang YK, Ogura K, Iwata S, Kim JH, Jeong WJ, et al. Post-radiation sarcoma: A study by the Eastern Asian musculoskeletal oncology group. PLoS One (2018) 13:e0204927.
3. Snow A, Ring A, Struycken L, Mack W, Koç M, Lang JE. Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A retrospective cohort study in the SEER cancer registries across 17 primary tumor sites. Cancer Epidemiol (2021) 70:101857.
- Keywords